NCT00332280View on ClinicalTrials.gov

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

March 31, 2010

Conditions
Gastrointestinal CancerProstate CancerGenital Neoplasms, Female
Interventions
DRUG

AMT2003

Trial Locations (2)

79111

Clinic SanaFontis, Freiburg im Breisgau

Unknown

Klinicki Centar Univerziteta Sarajevo - Klinika za gastroenterohepatologiju, Sarajevo

Sponsors
All Listed Sponsors
lead

Auron Healthcare GmbH

INDUSTRY

NCT00332280 - Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo | Biotech Hunter | Biotech Hunter